Efficacy and Safety of Very-Low-Dose Oral Minoxidil 1.25 mg in Male Androgenetic Alopecia

    Abhijeet Kumar Jha, Sidharth Sonthalia, Zeeshan, Keshavamurthy Vinay
    Image of study
    TLDR Low-dose oral minoxidil improves hair growth in male hair loss.
    The study evaluated the efficacy and safety of very low dose oral minoxidil (OM) at 1.25mg/day in male androgenetic alopecia (AGA). Thirty-two men with AGA were treated with OM monotherapy for 24 weeks. At 24 weeks, marked and mild improvement were seen in 43.8% and 40.6% of patients, respectively. Improvement in hair density and hair shaft diameter was statistically significant in 78.1% of patients. The study concluded that OM at a dose of 1.25 mg/day can be used in male AGA, although higher doses may be required if the response is suboptimal.
    Discuss this study in the Community →

    Cited in this study

    5 / 5 results

    Related

    3 / 3 results